Selected research
Industry Research
Gelatin Haemostatic Sponge Industry Research Report 2026
Market perspective
The global Gelatin Haemostatic Sponge market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gelatin Haemostatic Sponge is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gelatin Haemostatic Sponge is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gelatin Haemostatic Sponge is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gelatin Haemostatic Sponge include Aegis Lifesciences, Baxter International, CuraMedical, Cutanplast, Equimedical, Healthium, Medline Industries, Medzeel Lifescience and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gelatin Haemostatic Sponge market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gelatin Haemostatic Sponge Market by Company
Aegis Lifesciences
Baxter International
CuraMedical
Cutanplast
Equimedical
Healthium
Medline Industries
Medzeel Lifescience
Pfizer
Gelita Medical
Johnson & Johnson
Septodont
Goodwill Lifesciences
Gelatin Haemostatic Sponge Segment by Type
Porcine Gelatin Sponge
Cow Gelatin Sponge
Gelatin Haemostatic Sponge Segment by Application
Clinic
Hospital
Others
Gelatin Haemostatic Sponge Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gelatin Haemostatic Sponge market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gelatin Haemostatic Sponge and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gelatin Haemostatic Sponge.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gelatin Haemostatic Sponge manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gelatin Haemostatic Sponge by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gelatin Haemostatic Sponge in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Porcine Gelatin Sponge
- Cow Gelatin Sponge
Applications
- Clinic
- Hospital
- Others
Companies covered
- Aegis Lifesciences
- Baxter International
- CuraMedical
- Cutanplast
- Equimedical
- Healthium
- Medline Industries
- Medzeel Lifescience
- Pfizer
- Gelita Medical
- Johnson & Johnson
- Septodont
- Goodwill Lifesciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gelatin Haemostatic Sponge Market Size (2021-2032)
- 2.2.2 Global Gelatin Haemostatic Sponge Sales (2021-2032)
- 2.2.3 Global Gelatin Haemostatic Sponge Market Average Price (2021-2032)
- 2.3 Gelatin Haemostatic Sponge by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Porcine Gelatin Sponge
- 2.3.3 Cow Gelatin Sponge
- 2.4 Gelatin Haemostatic Sponge by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gelatin Haemostatic Sponge Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gelatin Haemostatic Sponge Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Gelatin Haemostatic Sponge Revenue of Manufacturers (2021-2026)
- 3.4 Global Gelatin Haemostatic Sponge Average Price by Manufacturers (2021-2026)
- 3.5 Global Gelatin Haemostatic Sponge Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gelatin Haemostatic Sponge, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gelatin Haemostatic Sponge, Product Type & Application
- 3.8 Global Manufacturers of Gelatin Haemostatic Sponge, Established Date
- 3.9 Global Gelatin Haemostatic Sponge Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aegis Lifesciences
- 4.1.1 Aegis Lifesciences Company Information
- 4.1.2 Aegis Lifesciences Business Overview
- 4.1.3 Aegis Lifesciences Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aegis Lifesciences Gelatin Haemostatic Sponge Product Portfolio
- 4.1.5 Aegis Lifesciences Recent Developments
- 4.2 Baxter International
- 4.2.1 Baxter International Company Information
- 4.2.2 Baxter International Business Overview
- 4.2.3 Baxter International Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter International Gelatin Haemostatic Sponge Product Portfolio
- 4.2.5 Baxter International Recent Developments
- 4.3 CuraMedical
- 4.3.1 CuraMedical Company Information
- 4.3.2 CuraMedical Business Overview
- 4.3.3 CuraMedical Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CuraMedical Gelatin Haemostatic Sponge Product Portfolio
- 4.3.5 CuraMedical Recent Developments
- 4.4 Cutanplast
- 4.4.1 Cutanplast Company Information
- 4.4.2 Cutanplast Business Overview
- 4.4.3 Cutanplast Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cutanplast Gelatin Haemostatic Sponge Product Portfolio
- 4.4.5 Cutanplast Recent Developments
- 4.5 Equimedical
- 4.5.1 Equimedical Company Information
- 4.5.2 Equimedical Business Overview
- 4.5.3 Equimedical Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Equimedical Gelatin Haemostatic Sponge Product Portfolio
- 4.5.5 Equimedical Recent Developments
- 4.6 Healthium
- 4.6.1 Healthium Company Information
- 4.6.2 Healthium Business Overview
- 4.6.3 Healthium Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Healthium Gelatin Haemostatic Sponge Product Portfolio
- 4.6.5 Healthium Recent Developments
- 4.7 Medline Industries
- 4.7.1 Medline Industries Company Information
- 4.7.2 Medline Industries Business Overview
- 4.7.3 Medline Industries Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Medline Industries Gelatin Haemostatic Sponge Product Portfolio
- 4.7.5 Medline Industries Recent Developments
- 4.8 Medzeel Lifescience
- 4.8.1 Medzeel Lifescience Company Information
- 4.8.2 Medzeel Lifescience Business Overview
- 4.8.3 Medzeel Lifescience Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Medzeel Lifescience Gelatin Haemostatic Sponge Product Portfolio
- 4.8.5 Medzeel Lifescience Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Gelatin Haemostatic Sponge Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Gelita Medical
- 4.10.1 Gelita Medical Company Information
- 4.10.2 Gelita Medical Business Overview
- 4.10.3 Gelita Medical Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Gelita Medical Gelatin Haemostatic Sponge Product Portfolio
- 4.10.5 Gelita Medical Recent Developments
- 4.11 Johnson & Johnson
- 4.11.1 Johnson & Johnson Company Information
- 4.11.2 Johnson & Johnson Business Overview
- 4.11.3 Johnson & Johnson Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Johnson & Johnson Gelatin Haemostatic Sponge Product Portfolio
- 4.11.5 Johnson & Johnson Recent Developments
- 4.12 Septodont
- 4.12.1 Septodont Company Information
- 4.12.2 Septodont Business Overview
- 4.12.3 Septodont Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Septodont Gelatin Haemostatic Sponge Product Portfolio
- 4.12.5 Septodont Recent Developments
- 4.13 Goodwill Lifesciences
- 4.13.1 Goodwill Lifesciences Company Information
- 4.13.2 Goodwill Lifesciences Business Overview
- 4.13.3 Goodwill Lifesciences Gelatin Haemostatic Sponge Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Goodwill Lifesciences Gelatin Haemostatic Sponge Product Portfolio
- 4.13.5 Goodwill Lifesciences Recent Developments
5 Global Gelatin Haemostatic Sponge Market Scenario by Region
- 5.1 Global Gelatin Haemostatic Sponge Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gelatin Haemostatic Sponge Sales by Region: 2021-2032
- 5.2.1 Global Gelatin Haemostatic Sponge Sales by Region: 2021-2026
- 5.2.2 Global Gelatin Haemostatic Sponge Sales by Region: 2027-2032
- 5.3 Global Gelatin Haemostatic Sponge Revenue by Region: 2021-2032
- 5.3.1 Global Gelatin Haemostatic Sponge Revenue by Region: 2021-2026
- 5.3.2 Global Gelatin Haemostatic Sponge Revenue by Region: 2027-2032
- 5.4 North America Gelatin Haemostatic Sponge Market Facts & Figures by Country
- 5.4.1 North America Gelatin Haemostatic Sponge Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gelatin Haemostatic Sponge Sales by Country (2021-2032)
- 5.4.3 North America Gelatin Haemostatic Sponge Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Gelatin Haemostatic Sponge Market Facts & Figures by Country
- 5.5.1 Europe Gelatin Haemostatic Sponge Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gelatin Haemostatic Sponge Sales by Country (2021-2032)
- 5.5.3 Europe Gelatin Haemostatic Sponge Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Gelatin Haemostatic Sponge Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gelatin Haemostatic Sponge Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gelatin Haemostatic Sponge Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gelatin Haemostatic Sponge Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gelatin Haemostatic Sponge Market Facts & Figures by Country
- 5.7.1 South America Gelatin Haemostatic Sponge Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gelatin Haemostatic Sponge Sales by Country (2021-2032)
- 5.7.3 South America Gelatin Haemostatic Sponge Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Gelatin Haemostatic Sponge Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gelatin Haemostatic Sponge Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gelatin Haemostatic Sponge Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gelatin Haemostatic Sponge Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Gelatin Haemostatic Sponge Sales by Type (2021-2032)
- 6.1.1 Global Gelatin Haemostatic Sponge Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Gelatin Haemostatic Sponge Sales Market Share by Type (2021-2032)
- 6.2 Global Gelatin Haemostatic Sponge Revenue by Type (2021-2032)
- 6.2.1 Global Gelatin Haemostatic Sponge Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gelatin Haemostatic Sponge Revenue Market Share by Type (2021-2032)
- 6.3 Global Gelatin Haemostatic Sponge Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gelatin Haemostatic Sponge Sales by Application (2021-2032)
- 7.1.1 Global Gelatin Haemostatic Sponge Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Gelatin Haemostatic Sponge Sales Market Share by Application (2021-2032)
- 7.2 Global Gelatin Haemostatic Sponge Revenue by Application (2021-2032)
- 7.2.1 Global Gelatin Haemostatic Sponge Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gelatin Haemostatic Sponge Revenue Market Share by Application (2021-2032)
- 7.3 Global Gelatin Haemostatic Sponge Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gelatin Haemostatic Sponge Value Chain Analysis
- 8.1.1 Gelatin Haemostatic Sponge Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gelatin Haemostatic Sponge Production Mode & Process
- 8.2 Gelatin Haemostatic Sponge Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gelatin Haemostatic Sponge Distributors
- 8.2.3 Gelatin Haemostatic Sponge Customers
9 Global Gelatin Haemostatic Sponge Analyzing Market Dynamics
- 9.1 Gelatin Haemostatic Sponge Industry Trends
- 9.2 Gelatin Haemostatic Sponge Industry Drivers
- 9.3 Gelatin Haemostatic Sponge Industry Opportunities and Challenges
- 9.4 Gelatin Haemostatic Sponge Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst